ATE223227T1 - Verwendung von lbp zur sepsistherapie - Google Patents

Verwendung von lbp zur sepsistherapie

Info

Publication number
ATE223227T1
ATE223227T1 AT98928139T AT98928139T ATE223227T1 AT E223227 T1 ATE223227 T1 AT E223227T1 AT 98928139 T AT98928139 T AT 98928139T AT 98928139 T AT98928139 T AT 98928139T AT E223227 T1 ATE223227 T1 AT E223227T1
Authority
AT
Austria
Prior art keywords
lbp
therapeutic agent
sepsis therapy
sepsis
therapy
Prior art date
Application number
AT98928139T
Other languages
German (de)
English (en)
Inventor
Ralf Reiner Schumann
Norbert Lamping
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Application granted granted Critical
Publication of ATE223227T1 publication Critical patent/ATE223227T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751Bactericidal/permeability-increasing protein [BPI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98928139T 1997-07-11 1998-04-04 Verwendung von lbp zur sepsistherapie ATE223227T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19729810A DE19729810C2 (de) 1997-07-11 1997-07-11 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung
PCT/DE1998/000964 WO1999002178A1 (de) 1997-07-11 1998-04-04 Mittel zur sepsistherapie, seine herstellung und seine verwendung

Publications (1)

Publication Number Publication Date
ATE223227T1 true ATE223227T1 (de) 2002-09-15

Family

ID=7835437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928139T ATE223227T1 (de) 1997-07-11 1998-04-04 Verwendung von lbp zur sepsistherapie

Country Status (9)

Country Link
US (1) US6949512B1 (enExample)
EP (1) EP0999849B1 (enExample)
JP (1) JP2001509488A (enExample)
AT (1) ATE223227T1 (enExample)
DE (2) DE19729810C2 (enExample)
DK (1) DK0999849T3 (enExample)
ES (1) ES2183376T3 (enExample)
PT (1) PT999849E (enExample)
WO (1) WO1999002178A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2108372A1 (en) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Novel antimicrobial peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025476A1 (en) * 1993-04-30 1994-11-10 Incyte Pharmaceuticals, Inc. Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
EP0664814A1 (en) * 1993-08-18 1995-08-02 MorphoSys AG Lipopolysaccharide-binding and neutralizing peptides
WO1995008560A1 (en) * 1993-09-24 1995-03-30 Centocor, Inc. Novel peptides useful for inhibiting binding of lipopolysaccharides (lps) by lipopolysaccharide binding protein (lbp)
US5837810A (en) * 1994-03-15 1998-11-17 The Scripps Research Institute Polypeptides of lipopolysaccharide binding protein
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein

Also Published As

Publication number Publication date
DE59805440D1 (de) 2002-10-10
WO1999002178A1 (de) 1999-01-21
JP2001509488A (ja) 2001-07-24
US6949512B1 (en) 2005-09-27
DE19729810A1 (de) 1999-01-14
DK0999849T3 (da) 2003-01-06
DE19729810C2 (de) 2000-01-13
EP0999849B1 (de) 2002-09-04
PT999849E (pt) 2003-01-31
EP0999849A1 (de) 2000-05-17
ES2183376T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
DE69630890D1 (de) Peptid-immitierende substanzen in der krebstherapie
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
EA199800946A1 (ru) Концентрированный препарат антител
FI954978L (fi) Modifioidut proteiini- ja peptidilääkeaineet
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
FI963252L (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
ATE273388T1 (de) Veränderte menschliche c3-proteine
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
DE69434384D1 (de) Metalkomplexbildner
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
NZ508505A (en) Treatment of wounds using an Egr-1 transcription factor polypeptide
FI964227L (fi) Hepariinia sitova proteiini verenmyrkytyksen hoitoon ja menetelmät sen valmistamiseksi
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
ID21034A (id) Protein kinase dan penggunaannya
DE69831084D1 (de) Beta-defensine
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
ATE223227T1 (de) Verwendung von lbp zur sepsistherapie
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
PT983300E (pt) Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
EE9800108A (et) Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee